For research use only. Not for therapeutic Use.
Valproic acid-d14 sodium(Cat No.:S000532) is a deuterated form of the sodium salt of valproic acid, where all the hydrogen atoms are replaced with deuterium (d14 denotes the presence of fourteen deuterium atoms). This modification increases the molecular stability and changes the kinetic properties of the drug, useful for detailed pharmacokinetic and metabolic studies. Valproic acid itself is a widely used medication for treating epilepsy, and bipolar disorder, and for preventing migraine headaches. The deuterated version helps researchers understand drug metabolism and can potentially lead to the development of improved formulations with better efficacy and reduced side effects.
Catalog Number | S000532 |
Molecular Formula | C8HD14NaO2 |
Purity | ≥95% |
IUPAC Name | sodium;3,3,4,4,5,5,5-heptadeuterio-2-(1,1,2,2,3,3,3-heptadeuteriopropyl)pentanoate |
InChI | InChI=1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1/i1D3,2D3,3D2,4D2,5D2,6D2; |
InChIKey | AEQFSUDEHCCHBT-QBFUJCBMSA-M |
SMILES | CCCC(CCC)C(=O)[O-].[Na+] |